PT1553943E - Utilização do tenatoprazole para o tratamento do refluxo gastroesofágico - Google Patents

Utilização do tenatoprazole para o tratamento do refluxo gastroesofágico Download PDF

Info

Publication number: PT1553943E
Authority: PT; Portugal
Prior art keywords: tenatoprazole; gastroesophageal reflux; treatment; gen; tolerated
Prior art date: 2002-10-21

Application number

PT03778427T

Other languages

English (en)

Inventor

Francois Schutze

Herve Ficheux

Alain Taccoen

Yoshio Inaba

Michel Homerin

Suzy Charbit

Original Assignee

Mitsubishi Tanabe Pharma Corp

Sidem Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-21

Filing date

2003-10-21

Publication date

2008-08-20

2003-10-21 Application filed by Mitsubishi Tanabe Pharma Corp, Sidem Pharma Sa filed Critical Mitsubishi Tanabe Pharma Corp

2008-08-20 Publication of PT1553943E publication Critical patent/PT1553943E/pt

Links

ZBFDAUIVDSSISP-UHFFFAOYSA-N 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C ZBFDAUIVDSSISP-UHFFFAOYSA-N 0.000 title abstract 3
208000021302 gastroesophageal reflux disease Diseases 0.000 title abstract 3
229950008375 tenatoprazole Drugs 0.000 title abstract 3
230000000694 effects Effects 0.000 abstract 2
208000024891 symptom Diseases 0.000 abstract 2
208000032843 Hemorrhage Diseases 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
230000003257 anti-anginal effect Effects 0.000 abstract 1
230000001088 anti-asthma Effects 0.000 abstract 1
239000000924 antiasthmatic agent Substances 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
230000001079 digestive effect Effects 0.000 abstract 1
ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
201000006549 dyspepsia Diseases 0.000 abstract 1
230000002439 hemostatic effect Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
229940126409 proton pump inhibitor Drugs 0.000 abstract 1
239000000612 proton pump inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

PT03778427T 2002-10-21 2003-10-21 Utilização do tenatoprazole para o tratamento do refluxo gastroesofágico PT1553943E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0213113A FR2845915B1 (fr)	2002-10-21	2002-10-21	Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien

Publications (1)

Publication Number	Publication Date
PT1553943E true PT1553943E (pt)	2008-08-20

Family

ID=32050603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT03778427T PT1553943E (pt)	2002-10-21	2003-10-21	Utilização do tenatoprazole para o tratamento do refluxo gastroesofágico

Country Status (17)

Country	Link
US (2)	US20070066659A1 (pt)
EP (2)	EP1553943B1 (pt)
JP (1)	JP2006508083A (pt)
KR (1)	KR101186034B1 (pt)
CN (2)	CN102920705A (pt)
AT (1)	ATE395060T1 (pt)
AU (1)	AU2003285426A1 (pt)
BR (1)	BR0315458A (pt)
CA (1)	CA2503212C (pt)
CY (1)	CY1108248T1 (pt)
DE (1)	DE60321025D1 (pt)
DK (2)	DK1553943T3 (pt)
ES (2)	ES2412395T3 (pt)
FR (1)	FR2845915B1 (pt)
PT (1)	PT1553943E (pt)
SI (1)	SI1553943T1 (pt)
WO (1)	WO2004037255A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2845916B1 (fr) *	2002-10-21	2006-07-07	Negma Gild	Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) *	2002-10-21	2006-07-07	Negma Gild	Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) *	2002-12-16	2006-07-28	Negma Gild	Enantiomere(-)du tenatoprazole et son application en therapeutique
FR2871800B1 (fr) *	2004-06-17	2006-08-25	Sidem Pharma Sa Sa	Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv)	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
JPH0643426B2 (ja)	1986-07-25	1994-06-08	東京田辺製薬株式会社	イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
SE9603725D0 (sv) *	1996-10-11	1996-10-11	Astra Ab	New teatment
EP2263660B1 (en) *	1998-05-18	2017-09-27	Takeda Pharmaceutical Company Limited	Orally disintegrable tablets
CA2362930C (en) *	1999-02-26	2010-10-05	Nitromed, Inc.	Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
SE0100823D0 (sv) *	2001-03-09	2001-03-09	Astrazeneca Ab	Method I to obtain microparticles
SE9903831D0 (sv) *	1999-10-22	1999-10-22	Astra Ab	Formulation of substituted benzimidazoles
AU2003241464A1 (en) *	2002-05-17	2003-12-02	Eisai Co., Ltd.	Compositions and methods using proton pump inhibitors
FR2845916B1 (fr) *	2002-10-21	2006-07-07	Negma Gild	Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) *	2002-10-21	2006-07-07	Negma Gild	Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) *	2002-12-16	2006-07-28	Negma Gild	Enantiomere(-)du tenatoprazole et son application en therapeutique
FR2871800B1 (fr) *	2004-06-17	2006-08-25	Sidem Pharma Sa Sa	Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique

2002
- 2002-10-21 FR FR0213113A patent/FR2845915B1/fr not_active Expired - Fee Related
2003
- 2003-10-21 AT AT03778427T patent/ATE395060T1/de active
- 2003-10-21 EP EP03778427A patent/EP1553943B1/fr not_active Expired - Lifetime
- 2003-10-21 ES ES08000893T patent/ES2412395T3/es not_active Expired - Lifetime
- 2003-10-21 CA CA2503212A patent/CA2503212C/fr not_active Expired - Fee Related
- 2003-10-21 CN CN2012102653624A patent/CN102920705A/zh active Pending
- 2003-10-21 EP EP08000893A patent/EP2014290B1/fr not_active Expired - Lifetime
- 2003-10-21 SI SI200331298T patent/SI1553943T1/sl unknown
- 2003-10-21 DK DK03778427T patent/DK1553943T3/da active
- 2003-10-21 US US10/531,900 patent/US20070066659A1/en not_active Abandoned
- 2003-10-21 JP JP2004546114A patent/JP2006508083A/ja active Pending
- 2003-10-21 CN CNA2003801071998A patent/CN1753674A/zh active Pending
- 2003-10-21 PT PT03778427T patent/PT1553943E/pt unknown
- 2003-10-21 KR KR1020057006851A patent/KR101186034B1/ko not_active Expired - Fee Related
- 2003-10-21 ES ES03778427T patent/ES2306905T3/es not_active Expired - Lifetime
- 2003-10-21 DE DE60321025T patent/DE60321025D1/de not_active Expired - Lifetime
- 2003-10-21 BR BR0315458-0A patent/BR0315458A/pt not_active Application Discontinuation
- 2003-10-21 AU AU2003285426A patent/AU2003285426A1/en not_active Abandoned
- 2003-10-21 DK DK08000893.1T patent/DK2014290T3/da active
- 2003-10-21 WO PCT/FR2003/003122 patent/WO2004037255A1/fr not_active Ceased
2008
- 2008-08-11 CY CY20081100837T patent/CY1108248T1/el unknown
2011
- 2011-02-25 US US13/035,547 patent/US20110152314A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN102920705A (zh)	2013-02-13
FR2845915B1 (fr)	2006-06-23
SI1553943T1 (sl)	2008-12-31
ES2306905T3 (es)	2008-11-16
AU2003285426A8 (en)	2004-05-13
CN1753674A (zh)	2006-03-29
WO2004037255A1 (fr)	2004-05-06
EP2014290B1 (fr)	2013-01-23
ATE395060T1 (de)	2008-05-15
JP2006508083A (ja)	2006-03-09
CA2503212A1 (fr)	2004-05-06
DK2014290T3 (da)	2013-05-06
EP1553943B1 (fr)	2008-05-14
US20070066659A1 (en)	2007-03-22
EP1553943A1 (fr)	2005-07-20
CA2503212C (fr)	2012-03-13
US20110152314A1 (en)	2011-06-23
DK1553943T3 (da)	2008-09-15
KR101186034B1 (ko)	2012-09-25
KR20050090374A (ko)	2005-09-13
ES2412395T3 (es)	2013-07-11
DE60321025D1 (de)	2008-06-26
FR2845915A1 (fr)	2004-04-23
EP2014290A3 (fr)	2009-03-04
BR0315458A (pt)	2005-08-23
CY1108248T1 (el)	2014-02-12
EP2014290A2 (fr)	2009-01-14
AU2003285426A1 (en)	2004-05-13

Publication	Publication Date	Title
US6051585A (en)	2000-04-18	Single-dose antihistamine/decongestant formulations for treating rhinitis
WO2001039759A3 (en)	2002-01-17	Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
SE9600072D0 (sv)	1996-01-08	New oral formulation of two active ingredients II
EE200200062A (et)	2003-04-15	Monoaminoksüdaasi inhibiitorite kasutamine ravimite valmistamiseks rasvumuse raviks
SE9500422D0 (sv)	1995-02-06	New oral pharmaceutical dosage forms
MXPA04004842A (es)	2004-08-02	Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
WO2002069945A3 (de)	2003-01-30	Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
HUP0300725A2 (hu)	2003-11-28	Az inzulinrezisztencia-szindróma kezelése CGMP PDE5 inhibitorokkal
RU99118887A (ru)	2001-05-20	Применение ингибиторов желудочно-кишечной липазы
WO2004039325A3 (en)	2004-11-11	Treatment of pain with jnk inhibitors
ZA200403690B (en)	2005-03-08	Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI).
EP1086099A4 (en)	2002-01-02	COMPOUNDS BASED ON SULFONIC ACID OR SULFONYLAMINO N- (HETEROARALKYL) -AZAHETEROCYCLYLAMIDE
CA2433833A1 (en)	2002-07-25	Use of flumazenil in developing a drug for the treatment of alcohol dependence
TW200833321A (en)	2008-08-16	Pharmaceutical composition for treating hypertension, diabetes mellitus and cardiovascular diseases
PT1656131E (pt)	2011-06-07	Utilização de betaína para tratar claudicação intermitente
AU2003285426A8 (en)	2004-05-13	Use of tenatoprazole for the treatment of gastroesophageal reflux
EP1393738A4 (en)	2004-11-17	MEDICINE AGAINST DIABETES
IL162768A0 (en)	2005-11-20	Method of treatment of a patient requiring analgesia
SE9902597D0 (sv)	1999-07-06	New use
MXPA04001912A (es)	2004-07-23	Aminobenzofenonas novedosas.
TW200503666A (en)	2005-02-01	Treatment of type 1 diabetes with pde5 inhibitors
EP1099439A3 (en)	2003-03-26	Use of apo B secretion/MTP inhibitors
AU2001244999A1 (en)	2001-10-23	Naphthamide neurokinin antagonists for use as medicaments
BG108144A (en)	2004-09-30	New use
AU2003229656A1 (en)	2003-10-27	A pharmaceutical formulation for endonasal administration and its use in the treatment of rhinitic symptoms